|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3302549 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16725104.0 |
| Date of filing the European patent application | 2016-05-23 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/EP2016/061517 |
| Date | 2016-05-23 |
| (87) | Number | WO 2016/188935 |
| Date | 2016-12-01 |
| (30) | Number | Date | Country code |
| 15169199 | 2015-05-26 | EP |
| (72) |
KLEIN, Christian, CH
HERTING, Frank, DE
DANGL, Markus, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sudėtinė terapija naudojant anti CD20 antikūną su BCL-2 inhibitoriumi ir MDM2 inhibitoriumi |
| COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BCL-2 INHIBITOR AND A MDM2 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2022-05-11 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-05-23 |